Deprescribing in a multimorbid older adult: A case vignette study among community pharmacists and primary care physicians

Basic Clin Pharmacol Toxicol. 2023 Dec;133(6):729-740. doi: 10.1111/bcpt.13899. Epub 2023 May 22.

Abstract

Collaborative deprescribing can include pharmacists' medication review with identification and suggestion of potential deprescribing targets to physicians. Case vignettes can be a valuable method for researching variations in clinical decision making, especially in settings unaccustomed to newer clinical approaches such as deprescribing. This study aimed to explore if pharmacists can identify deprescribing targets and if physicians would accept pharmacist's deprescribing rationales. A cross-sectional study was performed using an online case vignette based on a real-life elderly patient. Pharmacists were asked to indicate which medicines they would recommend deprescribing, alongside a rationale. Physicians were asked to state their acceptance of the proposed pharmacist's deprescribing suggestion. Pharmacists gave 1275 deprescribing rationales, and most were given for deprescribing opioids, NSAID and diuretics. Physicians would accept rationales to deprescribe a median of 10 medicines, while pharmacist would recommend deprescribing a median of six medicines. Most difference lays in deprescribing of preventative medicines. Healthcare providers share agreement on deprescribing targets, but pharmacists show hesitancies in making recommendations that could hamper potential collaboration. Action is needed to improve pharmacists' skills in recognizing deprescribing targets and confidence in making suggestions, which could lead to opening of possibilities for joint patient care.

Keywords: case vignette; deprescribing; multimorbidity; polypharmacy; primary care.

MeSH terms

  • Aged
  • Clinical Decision-Making
  • Cross-Sectional Studies
  • Deprescriptions*
  • Humans
  • Pharmacists
  • Physicians, Primary Care*